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The malachite green aptamer was originally engineered for binding specificity to 
malachite green (MG). The environment inside the aptamer’s electronegative binding pocket 
was previously harnessed to catalyze an ester cleavage via the stabilization of positively 
charged intermediates. In order to further explore and expand the catalytic potential of this 
molecule we have analyzed the binding and chemical properties of MG derivatives. The 
catalyzed reaction rate is approximately 2000-fold faster than the non-catalyzed reaction 
rate. This catalytic activity demonstrates the possible significance of electrostatic forces in 
RNA enzymes.  The ability of RNA to catalyze different reactions depending on the 
substrate provided would have been beneficial in an early RNA world.  
We have investigated the interactions between the malachite green aptamer and its 
ligands.  This investigation contributes to a better understanding of RNA aptamer 
interactions with small molecules which are crucial for drug development and RNA based 
catalysis. Equilibrium dialysis data suggests that MG binds exclusively within the binding 
pocket. On the other hand, pyronin Y which lacks the third phenyl ring of MG intercalates 
non-specifically. This confirms that all three phenyl rings have crucial interactions with 
RNA bases. Isothermal calorimetry data shows a more negative enthalpy value for the 
binding of tetramethylrosamine (TMR) to the MG aptamer than binding of MG to the MG 
aptamer. This agrees with the crystal structure of TMR bound to the MG aptamer that shows 
more extensive base stacking interactions compared to the MG : MG aptamer complex. 
TMR differs from MG by the addition of an oxygen between two of its phenyl rings, that 
gives TMR a more planar structure.  MG binding to the MG aptamer shows an entropy value 
increase compared to TMR binding to the MG aptamer. This agrees with available ab initio 
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calculations which show the development of an asymmetrical charge distribution across MG 
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Chapter 1 Introduction 
1.1 RNA world and its implications 
Our understanding of the function of ribonucleic acids (RNA) has increased 
dramatically since the original discovery of messenger RNA in 1961 [1]. At first, RNA’s 
only function was considered to be the transfer of information from deoxyribonucleic acids 
(DNA) to proteins, which were thought to be solely responsible for the complexity of life [2, 
3]. With the discovery of RNA based catalysis and the development of the RNA world 
hypothesis the perception of RNA’s function changed [4]. The RNA world hypothesis 
suggests that early life went through a stage where RNA was responsible for both 
information storage and catalytic function. The term RNA world was coined by W. Gilbert 
in a 1986 paper that reviewed RNAs with catalytic ability [5]. The RNA world hypothesis 
requires that RNA is able to self replicate, catalyze reactions and lead to the formation of 
peptide bonds. The discovery that the ribosome’s catalytic domain consists of RNA 
confirmed that RNA has the capacity to catalyze the formation of peptide bonds [6]. This 
discovery, along with artificially created catalytic RNA, has provided significant support for 
the RNA world hypothesis [7, 8].  
However, some important questions such as the formation of nucleotides still need to 
be answered. The chemistry involved in nucleotide formation from a prebiotic soup remains 
uncertain. The Miller experiment, where a mixture of CH4, NH3, H2O and H2 was passed 
through an electrical discharge, produced 11 of the amino acids involved in protein synthesis 
[9]. The reducing conditions used for these experiments were designed to mimic a 
theoretical early prebiotic atmosphere [10]. In 1960, J. Oro conducted similar experiments 
with reducing conditions, resulting in the formation of adenine and guanine from an 
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ammonium cyanide solution [11, 12]. Further experiments showed the formation of uracil 
and cytosine from cyanoacetylene and cyanate [13]. These experiments were based on the 
reducing nature of the pre biotic earth atmosphere. There is however no evidence that 
describes the atmosphere on earth five billion years ago. The formation of nucleotides with a 
ribose backbone from purines and pyrimidines is also problematic due to the limited stability 
of ribose [14].  
Another question often raised is why RNA not DNA formed the building blocks of 
prebiotic life. RNA and DNA are similar in that both molecules are capable of forming 
double helixes through complementary base pairing. The major difference is the extra 
hydroxyl group present on the 2′ carbon of the ribose sugar. This hydroxyl group makes 
RNA less stable in today’s environment, since this hydroxyl can facilitate an attack on the 
phosphodiester backbone. The extra hydrogen bond forming group allows RNA to form a 
greater variety of secondary structures and increases its catalytic potential. The inherent 
stability of DNA suits its purpose in current biology as a medium for information storage. 
However, in the early prebiotic stage, the greater range of structural and catalytic function 
offered by RNA would have been beneficial. Depending on the nature of the prebiotic 
environment, the instability of RNA may not have been a significant problem [15, 16].  
Further evidence of RNA’s importance was obtained with the completion of the 
human genome project that suggested a correlation between the increased non-protein 
coding regions and the complexity of humans versus other organisms. Many of these non-
protein coding regions are transcribed into RNAs that have roles in the regulation of 
transcription and translation levels [17-19].   
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1.2 RNA secondary structure 
 RNA forms diverse secondary structures; the nomenclature for some of the common 
motifs is detailed below in Figure 1.1. Secondary structures are comprised of canonical 
(Watson-Crick) and non-canonical base pairs that are stabilized through hydrogen bonding 
and base stacking interactions. 
 
 
Figure 1.1  Depiction of several secondary structure elements formed by RNA. In green are 
Watson Crick base pairs; red represents non Watson Crick base pairing or non 
paired bases, blue represents phosphate backbone [20]. 
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 RNA is also capable of forming tertiary structures through the interactions of 
secondary structure elements similar to proteins. The hammerhead ribozyme is a good 
example of such tertiary interactions and is discussed in the next section.  
1.3 RNA enzymes 
The first catalytic RNA was discovered in 1982, when the precursor ribosomal RNA 
of Tetrahymena thermophila was shown to be able to excise an intron in the absence of the 
protein complex thought to be responsible for the cleavage [21].  This observation led to the 
discovery of RNA’s catalytic potential that earned Thomas Cech (for his work with introns) 
and Sidney Altman (for the discovery of catalytic properties of ribonuclease P) the Nobel 
Prize in 1989 [4]. Ribonuclease P (RNase P) is a ribonucleoprotein complex that is 
responsible for the cleavage of precursor transfer RNA (tRNA) molecules [22]. In 1983, 
Altman showed that the RNA was capable of catalysis in the absence of the protein subunits 
under high magnesium concentrations [23]. Since then, a wide variety of catalytic RNAs 
have been identified including the ribosome complex that is responsible for peptide bond 
formation [6]. Catalytic RNAs are also called ribozymes. Ribozyme structures have unique 
electrostatic pockets that can serve as active sites for catalytic processes [24]. The 
interactions between nucleotides include: Watson-Crick and non Watson-Crick base pairing, 
hydrogen bonding, base stacking and hydrophobic interactions between aromatic rings, 
allowing for the formation of a variety of different RNA structures. The discovery of novel 
structures is on going, some of which have distinct binding pockets for substrates or 




1.3.1 Hammerhead ribozyme 
The hammerhead ribozyme is a naturally occurring ribozyme found in plant viruses. 
This ribozyme cleaves phosphodiester bonds through an in- line or Sn2(P) like reaction, 
shown in Figure 1.2a [26, 27]. The cleavage is an important step in the viroid replication 
cycle to produce unit length products [28]. The minimal hammerhead ribozyme structure, 
required for catalytic activity, consists of three base paired stem regions flanking the 
catalytic core shown in Figure 1.2b. The core consists of 15 nucleotides most of which are 
invariant. Based on the structure of the full length hammerhead ribozyme shown in Figure 
1.2c, the G5 nucleotide is responsible for positioning the nucleotide within the cleavage site, 
while the G12 and G8 residues are in position for base and acid catalysis, respectively. The 
full length hammerhead ribozyme has a 1000 fold activity over the minimal hammerhead 
sequence due to tertiary interactions [29]. The stem II loop interacts with the stem I bulge 
resulting in changes in the catalytic core, repositioning the G5, G12 and G8 residues for 
optimal activity. The role of these tertiary interactions is similar to tertiary interactions in 
proteins, illustrating that RNA is capable of not only secondary structural motifs but 




Figure1.2  A) Illustration of hammerhead ribozyme cleavage of a phosphodiester bond. Blue 
dashed lines represent bond forming, green dashed lines represent bond breaking, 
red dashed lines represent interaction of G12 and purple dashed line represent 
interaction of G8 B) Structure of minimal hammerhead ribozyme C) Structure of 
full length hammerhead ribozyme [27,29,31]. 
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1.3.2 Hairpin ribozyme 
  The hairpin ribozyme is another example of a naturally occurring ribozyme from 
the satellite RNA of a plant virus. The hairpin ribozymes self cleaves through an in- line or 
Sn2 (P) like reaction similar to the hammerhead ribozyme [28,32]. The transesterification or 
phosphodiester isomerization reaction occurs through acid-base catalysis and transition state 
stabilization. The minimal hairpin ribozyme structure consists of two internal loops and a 
four way helical junction shown in Figure 1.3. The interaction between these two loops 
creates the environment required for catalysis.  G8 from loop A is in a position to function 
as a general base, while A38 from loop B is in a position to function as a general acid. The 
involvement of G8 from loop A and A38 from loop B was investigated based on the pH 
dependence of the reaction. Since adenine should have a pKa of roughly 6 under an 
electronegative environment and guanine a pKa of 9.5, the reaction rate should increase as 
pH decreases. This relationship between pH and activity was confirmed, supporting the 
function of G8 and A38 as base and acid catalysts, respectively [33]. The role of the 




Figure 1.3  A) Secondary structure of hairpin ribozyme B) Crystal structure of hairpin 
ribozyme with loops colored to match secondary structure [33]. 
1.3.3 Hepatitis delta virus ribozyme  
The hepatitis delta virus (HDV) ribozyme is the self cleaving ribozyme that is 
responsible for the cleavage of products from viral replication of the hepatitis delta virus 
[34]. It catalyzes the transesterification of the phosphate backbone similar to hammerhead 
and hairpin ribozymes. However in the HDV ribozyme the role of general acid has been 
assigned to a divalent metal that protonates the 5′ oxygen leaving group. The general base is 
the C75 which deprotonates the 2′ OH group. Figure 1.4 shows a comparison of the catalytic 
mechanisms of the three ribozymes discussed above. The HDV ribozyme also destabilizes 
its RNA substrate through conformational changes [35, 36]. A crystal structure of the C75U 
mutant shows that the RNA substrate undergoes an approximately 180o turn about the 
9 
 
scissile phosphate. The HDV ribozyme is comprised of five helixes which are connected by 
a double pseudoknot shown in Figure 1.5. The HDV ribozymes use of divalent metals and 
conformation changes are similar to protein ribonucleases, showing the capacity of RNA 
ribozymes to fulfill the role that proteins play in the world today [37].  
 
Figure 1.4 Illustration of suggested mechanisms of A) hammerhead ribozyme [29] B) 




Figure 1.5  A) Secondary structure of hepatitis delta virus ribozyme B) Crystal structure 
of hepatitis delta virus ribozyme with helixes colored to match secondary 
structure, in yellow is the magnesium ion [35, 36].  
1.4 RNA applications 
The ability to regulate cell activities on multiple levels while having a short life time 
made RNA a potential drug target. In order to develop applications using RNA either as a 
potential target or as an RNA based drug, a complete understanding of its binding and 
catalytic ability is required. There have been multiple attempts to develop RNA based 
therapies including antisense nucleic acids, short interfering RNA (siRNA) and aptamers 
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[38]. Antisense RNA and siRNA are discussed below while aptamers and their applications 
will be discussed in more detail in the following section.  
Antisense nucleic acids are single stranded nucleic acid molecules that are 
complementary to mRNA. They function by binding to mRNA sequences preventing 
translation due to steric hindrance. Antisense RNA binds to their complementary mRNA by 
hydrogen bond interactions between Watson-Crick base pairs [39, 40].   Formivirsen 
(Vitravene; Isis Pharmaceuticals) is the first antisense drug to be approved by the United 
States Food and Drug Administration (FDA). It is a 21-base phosphorothioate 
oligodeoxynucleotide that is complementary to a key mRNA of the human cytomegalovirus 
[41-43].  
siRNA are double stranded RNA molecules approximately 20-25 nucleotides long 
that can lead to the cleavage of mRNA through the RNA interference (RNAi) pathway. The 
antisense strand of siRNA is integrated into a protein complex known as the RNA induced 
silence complex (RISC). This complex degrades the sense strand of the siRNA, and 
consequently binds to mRNA that is complementary to the antisense siRNA strand. The 
bound mRNA is then degraded, preventing translation [44, 45]. The complementary binding 
between siRNA and mRNA is similar to antisense RNA and mRNA. The siRNA binds to 
argonaute proteins which form the catalytic RISC. The phosphorylated 5′ of the siRNA 
interacts with the protein through aromatic stacking between the 5′ nucleotide and a tyrosine 
residue. The positioning of the 5′ nucleotide is aided by surrounding protein residues as well 
as a divalent magnesium cation [46, 47]. The first siRNA drug, bevasiranib (Opko Health) is 
currently in phase III clinical trials. It is designed to silence genes that produce the vascular 
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endothelial growth factor (VEGF), which is believed to be responsible for vision loss in wet 
age related macular degeneration (wet AMD) [48-50].  
Another strategy is to direct small molecule drugs towards RNA and interfere with 
the translational pathway. This would lead to the reduced production of protein molecules 
and inhibit cell growth [51, 52]. This strategy has lead to the development of antibacterial 
drugs including aminoglycosides, marcolides and other antibiotics. X-ray crystal structures 
have suggested that aminoglycosides bind to the 16S rRNA preventing translation leading to 
cell death [53]. Another promising target RNA is the trans-activation-responsive (TAR) 
RNA that is essential for viral replication. TAR RNA interacts with the HIV-1 regulatory 
protein Tat, this interaction can be inhibited by small molecule TR87 [54]. Most therapies 
involving targeting RNA are still in the research stage.  
siRNAs have been used to probe the function of genes, since they have the ability to 
turn off a gene without disrupting other cell functions. siRNAs have been successfully used 
to  identify genes related to apoptosis in retinal cells [55]. Methods involving high 
throughput RNA interference screening to identify new drug targets are now being 
developed [56]. Antisense RNA has been used to slow the ripening of tomatoes, by 
inhibiting the translation of polygalacturonase, which is responsible for cell wall degradation 
and fruit softening [57].  
The hammerhead ribozyme and the hepatitis delta virus ribozyme have been used to 
ensure homogeneous in vitro T7 polymerase transcription [58]. In vitro T7 polymerase 
transcriptions usually produce RNA with additional nucleotides on the 3′ prime end. In order 
to ensure homogeneity a self cleaving ribozyme, like the hammerhead ribozyme, sequence is 
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added at the 3 ′ end of the desired RNA sequence DNA template. After being transcribed the 
ribozyme cleaves itself off leaving the transcript products homogeneous. This method has 
been successfully used in combination with HPLC techniques to make RNA preparation 
more time and cost efficient [59]. 
1.5 RNA aptamers  
In order to investigate the catalytic potential of RNA and its role in evolution, it was 
important to understand the probability that random sequences of polynucleotide will form 
stable secondary structures with capacity for binding and catalysis. In 1990, A. D. Ellington 
and J.W. Szostak described a method for the in vitro selection of RNA molecules that bind 
to specific ligands. They coined the term aptamer from the Latin word aptus meaning to fit 
[60].  In the same year, a similar method called systematic evolution of ligands by 
exponential enrichment (SELEX) was developed by C. Tuerk and L. Gold [61].  The 
SELEX/ in vitro selection process involves creating a pool of random sequences of DNA 
with primers for polymerase chain reaction (PCR). This is followed by transcription to 
RNA, then selecting for binding sequences via an affinity column; with a target immobilized 
by a linker molecule to the column material. The RNA that binds is then eluted by addition 
of ligand or a denaturing wash buffer and reverse transcribed into DNA followed by another 
round of PCR. The process is repeated with the PCR products until a sequence is identified 
that has a high affinity for the target molecule. The complete process is illustrated in Figure 




Figure 1.6  Diagram of SELEX procedure. RNA transcribed from random pool of DNA 
is passed over column with target molecule, unbound RNA is washed off and 
bound RNA is eluted by competition to free target followed by reverse 
transcription and repetition of the process [60, 61]. 
This original method has been improved over the past decade and there are now 
multiple techniques based on the original SELEX these include capillary electrophoresis 
SELEX (CE-SELEX), toggle-SELEX and automated SELEX [62, 63]. CE-SELEX 
eliminates the need for a linker molecule, allowing the ligand to have more interaction with 
potential aptamer. The sequences that bind are separated based on motility change due to 
complex formation [64]. Toggle-SELEX method allows for the development of aptamers 
that have binding affinity for different isoforms of proteins using alternating cycles of 
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selection [65]. Automated SELEX has been developed and as the name suggests requires no 
manual intervention between steps [66].  
Aptamers are now defined as nucleic acid sequences which specifically bind to a 
target molecule. Target molecules range from small molecules, amino acids, proteins, and 
even whole cells [67-71].  RNA aptamers as the name suggests are composed of the 
ribonucleotides of adenine, guanine, cytosine and uracil, while DNA aptamers consist of the 
deoxyribonucleotides of adenine, guanine, cytosine and thymine.  The first discovery of a 
naturally occurring aptamer was in 2002; an mRNA structure that regulates gene expression 
by binding to flavin mononucleotide [72].   
A flavin mononucleotide aptamer was developed using in vitro selection in 1994 
[73]. This 35 nucleotide aptamer consist of two stem regions, an internal loop and a hairpin 
loop. The NMR solution structure showed that the FMN intercalates between G-G mismatch 
and G-U-A base triple. FMN also forms hydrogen bonds to the Hoogsteen edge of A26 as 
shown in Figure 1.7 [74]. Capillary electrochromatography has been used to detect FMN 
using capillaries linked covalently to FMN aptamers [75]. Development of aptamer based 
detection systems is a growing field and aptamers are being used in flow cytometry, affinity 




Figure 1.7  Suggested hydrogen bond interactions between A26 and FMN. Hydrogen 
bonds are shown in red dashed lines [74]. 
Aptamers have also been used to understand the interactions between antibiotics and 
RNA. Neomycin B is an antibiotic that binds to RNA preventing cell functions [80]. 
Aptamers developed in 1995 using in vitro selection showed that Neomycin B binding took 
place within hairpin loops [81]. The NMR solution structure showed that Neomycin B is 
sandwiched between a G-U mismatch and an adenine. It has been suggested that binding 
interaction includes electrostatic contacts between Neomycin B’s positively charged 
ammonium groups and backbone phosphates of the RNA. The binding interaction also 
includes hydrogen bonding between rings of Neomycin B and bases of the RNA [82]. This 
was confirmed by thermodynamic parameters determined by isothermal titration calorimetry 
using a variety of buffers with different ionic strengths [83]. A Spectinomycin aptamer 
developed by a combination of in vivo and in vitro selection has been used to confer 
antibiotic resistance to Escherichia coli [84].  
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Recent work with aptamers has lead to the development of therapeutic strategies 
including the first FDA approved aptamer drug, Pegaptanib, a pegylated modified 
oligonucleotide aptamer that selectively binds to an isoform of vascular endothelial growth 
factor [85].  Aptamer based therapies are being developed that included antiviral strategies. 
For example the TAR aptamer that upon binding to TAR RNA element inhibits TAR 
binding to Tat [86-88]. This reduces transcription levels of HIV-1. The TAR aptamer forms 
a kissing complex with the TAR RNA element, shown in Figure 1.8. The aptamer forms 
complementary Watson-Crick base pairs with TAR RNA element, the structure is stabilized 
by stacking interactions of a G-A non canonical pair. Hydrogen bonding was also detected 
between U5 of the aptamer and A11 of the TAR RNA element [69].  
 
Figure 1.8  TAR aptamer and TAR RNA element in kissing loop complex. The slabs 
represent nucleotide bases, when two bases are direct at each other they 
represent hydrogen bond interactions [69]. 
18 
 
The formation of kissing complexes, hairpin loops, and internal loops, which are 
naturally occurring RNA motifs, in in vitro selected molecules emphasizes the ability of 
RNA to form secondary structures with binding affinities for other molecules. This supports 
the idea that short RNA molecules could have developed function, and therefore have been a 
starting point for molecular evolution.  
1.5.1 Catalytic aptamers 
Methods similar to SELEX have been used to develop nucleic acid sequences with 
catalytic ability, artificial ribozymes. Artificial ribozymes have been selected for the 
catalysis of a variety of reactions including transesterification, alkylation, and peptide bond 
formation [89-92]. This modified SELEX uses the presence of catalysis to select sequences 
to be amplified. This method usually requires that the detection of catalysis must also allow 
for isolation of catalytic sequences. For example, random sequences were mixed with 
iodoacetyl derivative of biotin, self alkylation biotinylates the sequences allowing for 
separation from non catalytic sequences [90].  
Another approach to obtain catalytic sequences has been to develop aptamers that 
bind to transition state analogs. This method has been successfully used to develop catalytic 
antibodies. A 35 nucleotide aptamer was developed to target N-methylmesoporphyrin 
(NMMP), which is an analog of a possible transition state of the metalation reaction of 
mesoporphyrin [93, 94]. This aptamer had an observed rate acceleration of 460 over 
background. It is theorized that the acceleration is due to the aptamers preference for a 
distorted structure of the substrate. Thus the aptamer changes the planarity of the substrate 
stabilizing the transition state. Based on secondary structure prediction the aptamer has a 25 
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nucleotide internal loop with a 5 nucleotide stem, the loop is assumed to be site of binding 
[94]. 
1.6 Malachite green aptamer 
1.6.1 Malachite green aptamer: Development 
The malachite green aptamer (MG aptamer) was evolved by SELEX using malachite 
green dye (MG) as the target molecule. The MG aptamer shown in Figure 1.9a was 
originally developed as part of a new gene expression analysis strategy shown in Figure 1.9b 
[95]. This strategy involved the hybridization of MG aptamer to an mRNA sequence. MG, a 
triphenylmethane dye shown in Figure 1.9c, would be introduced and bind to the MG 
aptamer. MG could then be excited by red laser light causing the formation of radicals that 
would cleave off the 5′-cap. The cleavage of the 5′-cap would lead to degradation of mRNA 
attached to the aptamer [95, 96]. However, with the discovery of siRNA this method of 
mRNA transcription termination became unnecessary. The interaction of MG aptamer with 
MG provided a useful model system to study the interactions between aptamer and ligand. 
Based on the structures determined by crystallography and later by nuclear magnetic 
resonance spectroscopy (NMR), the MG aptamer lacked structure in the absence of MG, 
obtaining a stable structure only upon binding to MG [97, 98]. This was consistent with the 
idea that aptamers form their secondary structure through stabilizing interactions with 
ligand, called adaptive binding. Both crystal and NMR structures suggested that the only 
interactions between the MG and the aptamer were based on stacking and electrostatics [97, 
98]. This allows for the study of the effect of electrostatic and stacking interactions without 
their effects being masked by hydrogen bonding. The ability of an RNA aptamer to catalyze 
a reaction by providing a specific electrostatic environment is suggestive of how earlier 
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RNAs may have played a role in the evolution of catalysis. Further investigation of the MG 
aptamer to discover the variety of reactions the binding pocket is able to catalyze is 
discussed in Chapter 2.  
 
Figure 1.9  A) Malachite green aptamer (blue) bound to MG, MG is shown with its three 
rings color coded. PBD 1Q8N. [98] B) Schematic for the use of the MG 
aptamer in a gene expression analysis technique[95] C) MG shown with 





1.6.2 Malachite green aptamer: Ligand 
1.6.2.1 A brief introduction to triphenylmethane dyes 
 Triphenylmethane dyes have triphenyl methane as their basic structure. 
Triphenylmethane dyes are used in medicine, food coloring, cosmetic products, household 
products, and in the paper and agriculture industries [99]. Triphenylmethane dye toxicity in 
waste water has been a growing concern. Current methods used to clean waste water include 
chemical processes which are costly, methods are being developed that employ biological 
processes that will be more environmentally friendly [100]. Triphenylmethane dyes like 
tetramethylrosamine (TMR) have been used as fluorescent tags to develop fluorescence 
resonance energy transfer detection systems. TMR and 6-carboxyfluorescein (FAM) are 
used as acceptor and donor molecules. Angiogenin aptamers were labeled at the 5 ′ and 3′ 
termini with TMR and FAM respectively. Binding to angiogenin brings 5′ and 3′ termini of 
the aptamer in closer proximity allowing for rapid detection [101]. Pyronin Y and Methyl 
green are used as staining agents in microbiology to identify RNA and DNA [102, 103]. 
Methyl green and MG have been shown to have inhibitory effect of cholinesterase [104]. 
MG will be discussed in more detail below. 
1.6.2.2 The malachite green dye 
 Malachite green dye or 4-[(4-dimethylaminophenyl)-phenyl-methyl]-N,N-dimethyl-
aniline, shown in Figure 1.9b has antiseptic, antibacterial and antifungal properties. It has 
been used to treat fish and fish eggs [105,106]. In 1992, MG was classified as a Class II 
health hazard. MG is suspected to cause liver tumor formation [107]. While its use in aqua 
agriculture has been reduced in North America, reports of misuse are present and require 
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analytical methods to monitor MG levels [108, 109]. MG has been found to inhibit electric 
eel acetylcholinesterase, an enzyme involved in neuron pathways [110]. 
 
1.6.3 Malachite green aptamer: Applications 
 
 The MG aptamer : MG interaction has been used to develop aptamer based detection 
techniques. The MG aptamer has been shown to be functional within yeast cells and was 
capable of regulating reporter genes [111]. The synthesis of fluorinated analogs of MG has 
been reported. The purpose of these analogs is to allow for the imaging in vivo. The MG 
aptamer would have to be integrated into a nucleic acid probe, that in the absence of target 
mRNA is hybridized. When bound to target mRNA, the MG aptamer is free to bind to MG.  
The MG aptamer would then localize 18F-labelled MG allowing for imaging of gene 
expression site. In order to undertake this approach they determined that the analogs with a 
2,4-difluro substitution and another with a 2- fluro substitution have the lowest toxicity 
[112].   
 
A binary form of the malachite green aptamer has already been used as a fluorescent 
detector of target nucleic acid sequences. MG binding to MG aptamer increases the 
fluorescence of the dye by 2000-fold. MG being a triphenylmethane dye has low 
fluorescence emission due to easy vibrational deexcitation. Binding to the MG aptamer 
restricts vibrational deexcitation and stabilizes MG in a planar conformation which leads to 
an increase in fluorescence. This property of the MG aptamer dye relationship has been used 
to develop aptameric sensors. The reporting domain was the MG aptamer which was 
hybridized to a recognition domain either ATP, FMN or theophylline aptamer. The theory is 
that the binding of recognition aptamer to its target stabilizes the formation of the MG 
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aptamer allowing for binding to MG which produces a detectable fluorescence signal. This 
method was quite successful and was capable of detecting theomycin concentrations from 2 
to 250 nM [113].  
 
Another detection system has been developed using a binary version of the MG 
aptamer. This system separates the MG aptamer into two strands shown in Figure 1.10. Each 
strand is hybridized to part of a nucleic acid sequence complementary to a target sequence. 
When bound to target sequence they bring the two strands of the MG aptamer together 
allowing for binding to MG. The increase in fluorescence by binding of MG is then 
detected. This probe has been shown to reliably detect the presence of target sequences and 
discriminate between 41 out of 42 possible substitutions in a 14 nucleotide DNA target 
sequence [114].  
 
Figure 1.10 Fluorescent detection using MG aptamer I) binary probe free in solution II) 
binary MG probe bound to complementary DNA. Deoxyribonucleotides are 




1.6.4 Malachite green aptamer: Structure  
 There is no available crystal or NMR structure for the MG aptamer in its free state. 
The structure is too unstable for NMR spectroscopy and crystal formation. A secondary 
structure has been generated by Kinefold website and will be discussed in Chapter 3. The 
binding of MG to the MG aptamer was initially investigated by X-ray crystallography. 
However due to lack of suitable crystals, the structure was ultimately obtained using an 
analog of MG, TMR [97]. The NMR structure of MG bound to the MG aptamer was later 
determined and compared to TMR aptamer complex; structures are shown in Figure 1.11 
[98]. These structures showed that MG and TMR both bind in the same pocket that is 




Figure 1.11  I) MG aptamer bound to MG dye, base quadruple (yellow), base triples (red 
and green), G8-C28 base pair (blue), tetraloop (purple) II) Structures of TMR 
and MG III) Crystal structure of MG aptamer bound to TMR. PBD 1F1T IV) 
NMR solution structure of MG aptamer bound to MG. PDB 1Q8N. [97,98]. 
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The structure of the MG aptamer bound to dye (Figure 1.11) consists of 2 stem 
regions, a binding pocket and a tetra loop.  The binding pocket consists of a base quadruple 
(C7, G24, G29, A31), base triples (C10, G23, A27) (U11, A22, A26), U-turn motif (U25, 
A26, A27, C28) and the G8-C28 base pair. The structures are stabilized by base stacking 
and hydrogen bond interactions. The base quadruple is stabilized by stacking onto the C6-
G33 pair, allowing it to participate in stacking interactions with MG.  The two base triples, 
while not directly involved in interactions with MG, form the top of the binding pocket. The 
U-turn motif performs the crucial task of connecting and thus stabilizing A26, A27 (from the 
base triples) as well as the C28 (from the G8-C28 base pair). The G8-C28 base pair forms 
stacking interactions with the dye, effectively trapping it between itself and the base 
quadruple. The U25 of the U-turn motif is a flexible element that closes the side of the 
binding pocket. The U-turn motif’s flexibility allows the MG aptamer to adapt to different 
MG derivatives [98]. 
1.6.5 Malachite green aptamer: Binding effect on MG dye 
The C13 NMR spectra of bound MG dye showed that binding to MG aptamer caused 
changes in the electronic structure of MG.  This suggested that binding not only affects the 
structure of the aptamer but also the ligand. Ab initio calculations showed that the 
electrostatic charge distribution across the rings of MG dye changed with the introduction of 
a negatively charged environment similar to one present within the MG aptamer binding 
pocket [115]. The structural changes caused by RNA binding were observed through 
ultraviolet/visible (UV/Vis) spectroscopy. A red shift of the absorption maxima from 616nm 
to 630nm indicates changes in the alignment of the phenyl rings. Molecular dynamics was 
used to show that base stacking interactions cause MG to adopt a coplanar conformation, 
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which has an extended π bond distribution, leading to the observed red shift [116].  The 
binding properties of the MG aptamer were further investigated with MG analogs and are 
discussed in Chapter 3.   
1.7 Summary of proposed research 
We will investigate the catalytic potential of the MG RNA aptamer using MG 
analogs. The MG analogs used will be MGOH, MGCOOCH3 and MGNCS. Binding 



















Chapter 2 Catalytic Capacity of the Malachite Green Aptamer 
2.1 Introduction 
2.1.1 Importance of electrostatic interactions 
 Most RNA catalytic mechanisms discussed in Chapter 1 were based on general acid 
and base catalysis or hydrogen bond interactions of neighboring nucleotides with some 
amount of stabilization as a result of electrostatic interactions. However, a recent paper 
suggests that electrostatic interactions in the hairpin ribozymes account for the major ity of 
the rate acceleration without direct participation by nucleobases [117]. More extensive work 
has been done to determine the role of electrostatics in the ribosome. Recent work by 
multiple labs suggests that the catalysis of peptide bond formation by the ribosome does not 
involve acid base catalysis but is primarily the result of electrostatic interactions. The 
catalytic mechanism of this ancient RNA enzyme is suggested to be based upon electrostatic 
stabilization of highly polarized transition states [118, 119]. Computational free energy 
calculations of the cleavage of RNA by endonuclease suggest that the inline attack that was 
believed to be the driving force might play only a small role in catalysis [120]. The inline 
attack mechanism for RNA cleavage by endonuclease is similar to the mechanism suggested 
to be responsible for RNA cleavage by the ribozymes mentioned in Chapter 1. The major 
role in catalysis of RNA cleavage by endonucleases is now suggested to be due to 
electrostatic stabilization of transition states; thereby illustrating the potential importance of 
the role of electrostatic interactions in RNA based catalysis [120]. The lack of hydrogen 
bonding seen in the MG aptamer: MG interaction allows for the investigation of the role of 
electrostatic interactions in RNA based catalysis without the interference of other catalytic 
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mechanisms. Here we present our results for the catalysis of the hydrolysis of malachite 
green isothiocyanate (MGNCS) by the MG aptamer.  
2.1.2 The MG aptamer initial catalytic activity 
 The MG aptamer was developed by SELEX to selectively bind MG [121]. The 
electrostatic nature of its binding pocket was first suggested to be important due to the lack 
of hydrogen bonding between the ligand and aptamer [122, 123]. It was confirmed using 
NMR spectroscopy and ab initio calculations that the MG aptamer changed the charge 
distribution and conformation of bound MG by electrostatic and base stacking interactions 
[124, 125]. Experiments with a derivative of MG suggested that the electronegative nature 
of the binding pocket could be used to stabilize positively charged transition state or reaction 
intermediates. An ester analog of MG, MG-OCOCH3 (Figure2.1a) was used to show that the 
aptamer was indeed capable of catalysis. The aptamer catalyzes the hydrolysis of the C-O 
bond 10-fold faster than reaction in absence of RNA. Though this seems quite a minimal 
increase in reaction rate, further analysis showed that the aptamer changed the mechanism of 
the reaction. The non-catalyzed hydrolysis of MG proceeds predominately via an OH¯ 
driven pathway, down to pH values of 4 or lower. On the other hand, the catalyzed reaction 
proceeds via a proton driven pathway. The mechanism of the OH¯ and proton driven 
pathways are shown in Figure 2.1b and 2.1c, respectively.  Compared to the non catalyzed 
proton driven reaction that occurs in the absence of the MG aptamer, the catalyzed reaction 
is approximately 1000 times faster [126].  In order to further investigate the catalytic 
potential, i.e. the ability for the pocket to catalyze different reactions, an isothiocyanate MG 
derivative was used. Since the binding pocket appears to stabilize positive charged transition 
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state intermediates via electrostatic and base stacking interactions, the proton driven 
hydrolysis of isothiocyanate should be favored when the ligand is bound to the aptamer. 
 
Figure 2.1  A) The structure of MGOCOCH3 in 2D and as 3D model. The model was 
generated in Chem3D PRO 11.0 B) Schematic of the –OH driven hydrolysis 
of MGOCOCH3 C) Shows a schematic of the H
+ driven hydrolysis of 
MGOCOCH3. The blue circles represent the MG aptamer binding pocket; the 
negative charges (purple) represent phosphate groups that contribute to the 




2.1.3 Malachite green isothiocyanate  
 MGNCS (Figure 2.2a) is a commercially available dye that is sold for use as a 
molecular probe. MGNCS has been used to photosensitize Staphylococcus aureus bacteria 
leading to reduced viability [127]. The isothiocyanate group reacts with amine groups of 
proteins and has been used in the development of a colorimetric method for detection of 
amines [128]. MGNCS hydrolysis has been reported and observed spectrophotometrically. 
In water the isothiocyanate group is hydrolyzed to an amine group. A side reaction also 
occurs that involves an OH¯ attack at the central carbon.  The OH¯ driven mechanism for 
hydrolysis is shown in Figure 2.2b. Isothiocyanate hydrolysis under acidic condition is 
considered to be very slow. This reaction mechanism is shown in Figure 2.2c [127]. The 
hydrolysis of MGNCS at very high acid concentrations is discussed in the results and 












Figure 2.2 A) Structure of MGNCS in 2D and 3D model structure. B) Shows a 
schematic of the –OH driven hydrolysis of MGNCS C) Shows a schematic of 
the H+ driven hydrolysis of MGNCS [127]. 
2.1.4 Ultra Violet and Visible Absorption Spectroscopy 
 UV/Vis absorption spectroscopy has previously been used to observe the MG 
aptamer’s catalysis of the hydrolysis of MG-OCOCH3 to MG-OH, as well as the 
background hydrolysis of MGNCS to MGNH2 in water [126, 127]. UV/Vis absorption 
spectroscopy detects absorption in the UV/Vis spectra from 200nm to 700nm. π→ π* 
transitions from bonding π energy level to anti bonding π* energy level and n→ π* 
transitions from non bonding energy level to anti bonding π* energy level have absorption 
peaks within the UV/Vis spectra [128]. Binding of MG to the MG aptamer causes the MG 
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rings to adopt a more coplanar conformation that extends the π bond system thereby 
lowering the π→π* transition energy and leading to the red shift of the absorption maxima 
from 616nm to 630nm [125].  
 The central parameter derived from UV/Vis absorption spectroscopy for our 
purposes is concentration. According to Beers law, which states that A= ε c l, where A is the 
absorbance, ε is the molar absorptivity, l is the path length and c is the concentration. Once 
the molar absorptivity has been determined using known concentrations, the concentration 
of any species can be measured and followed over time [129].  
2.2 Results and Discussion 
2.2.1 Characterization of Substrate and Product  
Both, the substrate MGNCS and the product MGNH2 were examined using UV/Vis 
spectroscopy to determine a suitable wavelength to observe changes during the hydrolysis 
reaction.  MGNCS and MGNH2 have distinctly different absorbance spectra (Figure 2.3). 
MGNCS has a main maximum at 629nm and a secondary maximum at 445nm, upon binding 
to the aptamer the maxima are red shifted to 642nm and 455nm, respectively. MGNH2 has a 
main maximum at 590nm and a secondary maximum at 513nm, upon binding to the aptamer 
the maxima are red shifted to 603nm and 530nm, respectively. Due to its isolation from 
other absorption regions, product formation inside the RNA was fo llowed at 530nm and 
background product formation at 513nm. This is similar to the absorption regions that were 
monitored for the MG-OCOCH3 hydrolysis, i.e. the secondary maxima were selected for 
observation of catalysis [126].  
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Figure 2.3  UV/Visible spectral of MGNCS (green) and hydrolysis product MGNH2 
(purple) A) unbound B) bound to RNA. Shows minor peak change from 
450nm to 513 nm for unbound and 450nm to 530nm for bound hydrolysis 
product. 
2.2.2 Hydrolysis of MGNCS  
The hydrolysis of MGNCS was studied both in the presence and absence of the MG 
aptamer using initial rate kinetics. In the absence of the MG aptamer, free MGNCS is 
hydrolyzed with an initial rate of 9.23 x 10-7 ± 3.76 x 10-8 mM/min at pH 5.0 and 25°C. 
Under the same conditions in the presence of an excess of the MG aptamer, to ensure that all 
MGNCS is bound, the reaction proceeds with a rate of 2.23 x 10-6± 1.01 x 10-7 M/s. This 
corresponds approximately to a 3- fold acceleration of the reaction over the reaction in the 




Figure 2.4  Comparison of the initial reaction rates of the MGNCS hydrolysis reaction. 
The initial reaction rates for the hydrolysis of MG- derivative at pH 5.0 in the 
presence (MG RNA+) and absence (MG RNA-) of the MG aptamer. 
At first glance, this acceleration appears lower than the effect observed for the 
hydrolysis of MG-OCOCH3. However, similar to the MG-OCOCH3 hydrolysis we find that 
the hydrolysis mechanism changes from an OH¯ driven pathway to a proton driven pathway 
within the aptamer. The pH dependence of the reaction rates (Figure 2.5) illustrate that the 
free MGNCS hydrolysis reaction rate increases with increasing pH. On the other hand, the 
bound MGNCS hydrolysis reaction rate decreases with increasing pH. This pH behavior is 
consistent with the idea that the hydrolysis reaction is OH¯ driven and proceeds via 
negatively charged transition states in the absence of MG aptamer. And within the MG 
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aptamer binding pocket the hydrolysis is proton driven and proceeds via positively charged 
transition states. However, as with the MG-OCOCH3 hydrolysis reaction, the MG aptamer 
has a greater affinity for the final product and thus there is no detectable turnover.  
 
Figure 2.5   pH dependence of the hydrolysis reaction in the presence of MG aptamer 
(green) and in the absence of MG aptamer (red). Values for pH curve were 
limited to pH5-pH 5.6 since at greater pH there was increase in OH¯ attack to 
the central carbon of MGNCS which changed the dye to its colorless carbinol 
form. Below pH 5 the RNA begins to get protonated resulting in loss of 
structure. 
In order to investigate the mechanism of the free MGNCS hydrolysis reaction the 
rate was observed at pH 1 and pH 11. As seen in Figure 2.6, the reaction at pH 11 
experiences reduction in absorption due to the conversion to colorless carbinol form of the 
dye. This can be attributed to an OH¯ attack at the central carbon. There is also an 
observable shift of the secondary maximum from 455nm to 513nm suggesting the formation 
of hydrolysis product MGNCS. The reaction at pH 1 also experiences a reduction in 
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absorption. This can be attributed to a protonation of the amine group reducing the extended 
π electron distribution. This reduction in absorbance is also observed for MG (Appendix 
Figure 2A). There is however no observable shift from 455nm to 513nm most likely due to 
the protonation of amine group which makes interpretation of UV/Vis spectra difficult. The 
presence of MGNH2 the hydrolysis product was detected by mass spectroscopy at low pH 






Figure 2.6  A) UV/Vis spectra showing the degradation of MG-NCS at pH 1. Presence of 
peak at 445nm indicates little detectable conversion to MG-NH2 B) Spectra 
showing the hydrolysis of MG-NCS to MG-NH2 at pH 11. Peak shifts from 
624nm to 586nm. Both reactions were carried out in the absence of aptamer. 
They indicate that in the absence of aptamer the reaction is OH¯ driven. t is in 
hours. 
The slow rate of hydrolysis at low pH in combination with the pH curves (Figure 
2.5) suggest that the MG aptamer binding pocket provides an electronegative environment 
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that stabilizes positive transition state intermediates, thus catalyzing the reaction via a proton 
driven pathway shown in Figure 2.7. 
 
 
Figure 2.7 Proton driven hydrolysis of MGNCS with blue circles representing the MG 
aptamer binding pocket. The negative charges (purple) drawn represent 
phosphate groups that contribute to the electronegative environment within 
the binding pocket. 
2.2.3 Comparison to hydrolysis at excess acidity 
In general the hydrolysis of isothiocyanates at low pH is considered to be very slow 
and in aqueous alkaline solution proceeds via an OH¯ driven pathway [130]. The reaction 
has been shown to proceed via a proton driven pathway under extremely strong acidic 
conditions. The hydrolysis reactions of various alkyl and aryl isothiocyanates were studied 
at 11.5 M to 8 M perchloric acid at 50oC. These studies were done by Joseph and coworkers 
in 1992 [131]. Their published data was used for the following extrapolation. The excess 
acidity scaling method is based on equation 2.1 [132]. 
log(kobs) – log (H
+) = m* X + pKBH+   (Equation 2.1) 
The plot of [log(kobs) - log(H
+)] versus the X value for the hydrolysis 4-
Methoxyphenyl isothiocyanate is shown in Figure 2.8. The kobs at low acid concentrations 
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can be estimated by extrapolation to the y intercept. The X value represents the excess 






Figure 2.8   Excess acidity plots according to equation (2.1) for 4-Methoxyphenyl 
isothiocyanate. Linear regression was done using Microsoft Excel.  
 The X values for aqueous perchloric acid mixtures can be calculated using reported 
polynomial coefficients 0.0335096 (a1), -0.000745044 (a2) and 0.0000222391 (a3) and 
equation 2.2 [132]. 
X = a1(wt%) + a2(wt%)
2 + a3(wt%)
3   (Equation 2.2) 
Using the calculated X values at 1 x 10-5 M perchloric acid (0.001wt% or 
approximately pH 5) and the linear regression equation from Figure 2.8, the rate for the 
proton driven hydrolysis of 4-Methoxyphenyl isothiocyanate was estimated to be 2.30 x 10-9 
mM/min at 50oC. Assuming that the reaction rate doubles every 10oC increase in 
temperature, the rate at 25oC was approximated to be 4.31 x 10-10 M/s. This agrees with the 
decrease in reaction seen from 50oC to 25oC at 11M perchloric acid [131]. A direct 
quantitative comparison cannot be made since the perchloric acid studies were done with 4-
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Methylphenylisothiocyanate and  4-Methoxyphenyl isothiocyanate. However, the rate of 
hydrolysis of MGNCS should be similar since their experiments with other aryl 
isothiocyanates showed only small differences in kobs with electron donating substitutions 
slightly increasing the reaction rates [131]. The reaction rate observed within the MG 
aptamer is approximately 2000-fold faster that the hypothetical proton driven pathway at pH 
5 (Figure 2.9).  This is similar to acceleration of the hydrolysis of the previously described 
MG ester analog via a proton driven pathway in free solution and confirms that the 
electronegative pocket stabilizes the positive transition state intermediates allowing for a 
proton driven pathway to proceed at an accelerated rate. The MG aptamer’s electronegative 
binding pocket stabilizes the protonation of the isothiocyanate nitrogen and the simultaneous 





Figure 2.9  Comparison of the initial reaction rates of the MGNCS hydrolysis reaction 
and hypothetical proton pathway (4-Methoxyphenyl isothiocyanate 
hydrolysis). The initial reaction rates for the hydrolysis of MGNCS derivative 
at pH 5.0 in the presence (MG RNA+) and absence (MG RNA-) of the MG 
aptamer. The y axis is broken since the activity of the hypothetical proton 
pathway is magnitudes smaller than observed rates. 
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The catalytic effect of the MG aptamer is considerable when compared to the same 
mechanism in solution. The comparison of catalyzed and non catalyzed mechanism has 
played an important role in supporting the importance of electrostatic catalysis. Since the 
reaction mechanism in free solution is almost never the same as the reaction that occurs 
within the catalytic pocket, the proper reference reaction is important to determine the 
energy involved in transition states and the stabilization provided by the enzyme. A review 
article published in 2006 illustrated the use of ab initio calculations to determine the 
activation energy required for enzymatic mechanism of various proteins to occur in the 
absence of protein [132]. Similar calculations involving the ribosome peptidyl transferase 
reaction have shown that a water assisted reaction dominates in free solution while within 
the ribosome due to the ribosome’s electrostatic effect, the reaction using the –OH group of 
the substrate dominates [119]. 
2.2.4 Catalytic pocket 
 Figure 2.10a shows the binding pocket of the MG aptamer containing MG. This 
NMR solution structure was used as a starting model to obtain a representation of MGNCS 
and MGOCOCH3 within the binding pocket. Structures were generated, by modifying the 
NMR solution structure of MG bound to the MG aptamer, using Chimera. The changes were 
made to the para position of ring C and angles were adjusted to eliminate steric hindrances. 
Figures 2.10b and 2.10c, show the functional groups -NCS and –OCOCH3 are in the vicinity 
of the phosphate backbone (ribbon) of the MG aptamer, in particular the phosphate groups 





Figure 2.10  A) Binding pocket of MG aptamer with MG bound B) Binding pocket of MG 
aptamer with MGOCOCH3 bound C) Binding pocket of MG aptamer with 
MGNCS bound. The nucleotides are color coded A (red), G (green), C 
(yellow) and U (blue). Block represents the nucleotide bases while ribbons 
represent the phosphate backbone. 
Figure 2.11 shows the same NMR structure as above; in combination with an 
electrostatic field map calculated by Delphi projected onto its solvent accessible surface. 
The charge distribution illustrates that the functional groups of the ligand are surrounded by 
a strongly electronegative environment (dark red patches). Also shown are the MG aptamer 





Figure 2.11  A) MG aptamer binding pocket with electrostatic potential map calculated by 
DELPHI. MGNCS is within the binding pocket, the isothiocyanate group  is 
surrounded by electronegative potential (red). B) MG aptamer binding pocket 
showing only the phosphate backbone. Distances are shown for phosphate 
(RNA) in orange to sulfur atom (isothiocyanate) in yellow.  
2.2.5 Further RNA catalytic activity exploration with MG derivatives 
MGOH and MGCOOCH3 where synthesized based on established methods 
(Appendix Figure 2F, 2G shows the synthesis scheme) [133, 134]. MGOH’s purpose was to 
explore the possibility that the MG aptamer could catalyze the formation of an ester bond. 
This would essentially be the reverse of the catalysis of the ester bond cleavage. However, 
no catalysis was observed in the presence of the aptamer. It was concluded that the entry of 
a carboxyl group, that would have a negative charge, is unfavorable. Most molecules that 
have carboxyl groups and are water soluble have low pKas, making this type of reac tion is 










MGCOOCH3 was synthesized in an attempt to introduce turnover functionality to the 
aptamer. The hydrolysis of MGCOOCH3 would yield MGCOO
- which would be rejected 
from the binding pocket opening a pathway to substrate turnover and true enzymatic 
activity. This reaction was not observed in the background or in the presence of the aptamer. 
It was concluded that this was due to the fact that methanol is a poor leaving group. In order 
to demonstrate a more catalytically efficient aptamer the synthesis of an ester with a 
different leaving group is required and will be pursued in future studies. Changes will be 
made to the R group seen in Appendix Figure 2G. 
2.3 Conclusions 
 We have successfully shown that the MG aptamer is capable of catalyzing at least 
two different reactions. This promiscuous nature of an RNA enzyme is not uncommon. For 
example, Tetrahymena Group I ribozyme has been shown to have catalytic promiscuity, 
although at slower rates [135]. Capping ribozymes are able to accept a broad range of 
nucleotide substrates. Two structurally distinct capping ribozymes have been reported to 
have the same promiscuous substrate specificity and appear to have the same mechanism 
[136].  
The capability of RNA to catalyze certain chemical reactions based on the 
availability of a variety of substrates could have allowed a single RNA to perform different 
functions in an early RNA world. This would also allow for a selection of useful functions 
and thus lead to the evolution of more specific RNAs from their promiscuous ancestors. The 
electrostatic properties of the MG aptamer are capable of catalyzing the hydrolysis of C-O 
and C-N bonds. This supports the importance of electrostatic interactions in RNA based 
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catalysis. The electrostatic potential map of the binding pocket supports the transition state 
stabilization as the driving force behind the catalysis of the isothiocyanate group which is 
surrounded by a strong electronegative potential. However, the lack of turnover means that 
the aptamer is still not a true enzyme. The difficulty to achieve turnover can be explained by 
the nature of the aptamer’s evolution based on binding affinity and the structural similarity 
of the substrate and the product. This is a consequence of an evolution based on substrate 
binding affinity and this difficulty can be overcome by designing a reaction that results in 
the product having a lower affinity than the substrate. Nevertheless, the ability of the MG 
aptamer to catalyze at least two different reactions confirms that electrostatic environment 
created by RNA folding can be favorable for catalysis in the presence of a suitable ligand, 
regardless of original evolutionary pressure that formed the fold.  
2.4 Materials and Methods 
2.4.1 Synthesis of RNA 
The MG aptamer used for UV/Vis kinetic studies was prepared enzymatically from a 
synthetic DNA template by using T7 RNA polymerase and unlabeled NTPs, as described 
previously [122]. To increase yield of the transcribed RNA, the DNA template was 
synthesized to include only purines in the first six transcribed nucleotides.  After 
transcription, the pyrophosphate was removed by centrifugation and the RNA was collected 
by precipitation with ethanol. The RNA was then separated from NTPs and abortion 
products by PAGE on 12% acrylamide gel. Followed by extraction from gel via 
electroelution. Further purification of the RNA involved a HiPrep 16/10 DEAE FF anion-
exchange column, followed by desalting on a HiPrep 26/10 Desalting column and 
lyophilization to dryness. The RNA was then resuspended in deionized water prior to use. 
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All columns used for RNA preparation were purchased from GE Healthcare, Uppsala, 
Sweden.  
2.4.2 Ligand preparation 
 
 Malachite green isothiocyanate was purchased from Invitrogen (Invitrogen 
corporation, Carlsbad, California).  The dye was weighed and dissolved in acetonitrile for 
storage as a 500μM stock solution. Malachite green amine was synthesized by introducing 
1ml of 0.1mM NaOAc buffer, pH 8 to 1ml of the 500μM Malachite green isothiocyanate 
solution and incubating at room temperature for 48 hrs. The resulting solution was purified 
by 1:1 chloroform: water extraction. The desired product was obtained in the aqueous layer. 
ESI mass spectrometry was used to confirm formation of desired product (Appendix Figure 
2C). 
MGOH derivative was synthesized by refluxing 4-Bromo N,N-dimethylaniline, in 
the presence of magnesium ribbon and iodine, in THF at 65oC for 1hr. The solution was then 
cooled and 4-hydroxy methyl benzoate was added. This was followed by refluxing for 10 
min at 70oC and then acidification by adding 1M HCl. The dye was purified by flash 
chromatography using 8:1:1 dichloromethane, ethyl acetate and methanol. ESI mass 
spectrometry was used to confirm formation of desired product (Appendix Figure 2D). 
MGCOOCH3 was synthesized by stirring dimethylaniline and formyl 4-methyl 
benzaldehyde in concentrated HCl for 12 hrs under nitrogen. This was followed by 
neutralization with NaOH and extraction into ether. The solution was then dried with 
sodium sulfate. The leuco-base was purified by flash chromatography using 9:1 hexane and 
ethyl acetate. The leuco-base was dissolved in chloroform and an excess of 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone. The dye was then purified by flash chromatography using 5:1 
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chloroform and methanol. ESI mass spectrometry was used to confirm formation of desired 
product (Appendix Figure 2E). 
 
2.4.3 UV/Visible spectroscopy kinetic studies 
 
 MGNCS and MGNH2 have distinctly different UV/Vis absorption spectra. This 
allowed for the observation of the formation of MGNH2. MGNCS had a main maximum at 
629 nm and a secondary maximum at 445 nm. Upon binding to the RNA, the maxima were 
red shifted to 642 nm and 455 nm.  MGNH2 had a main maximum at 590 nm and a 
secondary maximum at 513 nm. Upon bind to the RNA, the maxima were red shifted to 
603nm and 530nm. Due to its isolation from other absorption regions, catalyzed product 
formation was observed at 530 nm. Hydrolysis of MGNCS bound to RNA was monitored by 
observing an increase in absorbance at 530 nm with a Varian CARY 4000 UV/Vis 
spectrophotometer (Varian Inc, Palo Alto, California). The background hydrolysis of 
unbound MGNCS was monitored by observing increase in absorbance at 513 nm. In order to 
obtain initial reaction rates, the reactions were monitored for 200 minutes. The reaction 
conditions were MGNCS (2μM), MG aptamer (32μM), NaOAc (50mM), KCl (100mM) at 
pH values ranging from 5 to 6. The background reactions were observed under identical 
buffer conditions with the exception of RNA.  Low and high pH background hydrolysis 
were unbuffered. The pH was adjusted using 11M HCl and 5M NaOH respectively.  The 







2.5 Future Work 
2.5.1 Study interaction of amino acids with MGNCS 
Two reactions were reported when MGNCS was dissolved in a cellular protein 
solution [137]. We have reported the study of the hydrolysis of MGNCS to yield MGNH2; 
in the future we will attempt to study the attack of an amine at the carbon of MGNCS to 
yield a thiourea [138]. Taking into account the binding pockets electronegative environment 
we will use lysine, arginine and histidine as the initial substrates. These amino acids have a 
positively charged group and the negatively charged carboxyl group is six bonds away from 
the amino group in the case of lysine and arginine. Histidine has only four bonds between 
the carboxyl and the amine group but has a five ring structure that could have additional 
interactions within the binding pocket that might allow for a shift in pKa of the carboxyl 
group.  
2.5.2 Use of SELEX to develop more efficient MG aptamer ribozyme  
The MG aptamer has shown considerable catalytic potential based on a sequence that 
was selected for binding affinity. We will attempt to develop a more efficient catalytic MG 
aptamer using SELEX with a pool of nucleotides “doped” with the MG aptamer template. 
Doping has successfully been used to increase activity of aptamers [139]. We will then 
proceed to a two stage selection process where the first column will select for affinity and 
the second column that selects for catalytic activity. The first column will involve a wash to 
remove non binding RNA followed by introduction of free dye that will compete for binding 
and release the target RNA from the column. The second column will involve collection of 
RNA that cleaves the bond between the linker and dye molecule releasing both dye and 
RNA. Aliquots with both dye and RNA will be selected for the next round of SELEX. The 
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affinity of the aptamer will be adjusted for greater affinity for substrate by performing 
multiple rounds of affinity selection with a wash that contains the product dye eliminating 
aptamers that would have a greater affinity for the product.  
2.5.3 Investigate the possibility of a positive binding pocket with SELEX 
The phosphate backbone of RNA allows for the generation of negatively charged 
pocket. However, the electronegative pocket does limit the number of reactions that are 
possible. Thus, we will attempt to generate a MG aptamer that has a high affinity for a 
negatively charged MG derivative either MGO- or MGCOO- dye.  This would possibly 
involve interactions with metal ions within the binding pocket to stabilize the negative 
charge on the dye. The SELEX process will involve metal ion containing buffers. Again the 
pool of nucleotides will be doped with the MG aptamer template and bound RNA will be 
collected via competition to free ligand. Metal ions generally coat the charged phosphate 
backbone of RNA, thereby stabilizing folded structures. Many naturally occurring 
ribozymes rely on metal ions for structural stability and catalytic activity [140]. For example 
Mn2+ has been shown to have a role in both structure and catalytic activity of Tetrahymena 









Chapter 3 Binding Studies of Malachite Green and Derivatives 
3.1 Introduction 
3.1.1 RNA aptamer binding 
RNA aptamers are short nucleotide sequences that have high affinity for a target 
molecule. These sequences have been evolved in vitro with the sole purpose of binding to 
the target molecule [143-145]. Since no evolutionary pressure is placed on the aptamer in 
the absence of target molecule, most aptamers lack a defined rigid structure in their ligand 
free form. A stable complex is formed between the ligand and aptamer by a combination of 
hydrogen bonding, base stacking and electrostatic interactions. This type of binding is 
referred to as adaptive binding or ligand dependent folding [146-148]. Protein binding 
pockets can contain of 20 different amino acids that can create shape and charge 
complementarity, provide hydrogen bonding and general acid-base interactions that confer 
enzymatic activity. On the other hand, RNA aptamer binding pockets rely mainly on base 
stacking interactions and hydrogen bonding [149-151]. The latter does play an important 
role in specificity. For example, the theophylline aptamer has a 10000 times higher affinity 
for theophylline compared to caffeine, which differs only by one methyl group. The bulky 
methyl group replaces a hydrogen atom which is involved in hydrogen bonding to a cytosine 
thereby decreasing affinity to aptamer [152]. Base stacking is not limited to flat aromatic 
compounds but also plays a crucial role in interactions with aminoglycoside, amino acids 





3.1.2 Malachite green aptamer binding  
As mentioned in Chapter 1 the structure determination of the MG aptamer bound to 
MG by X-ray crystallography was unsuccessful due to the lack of crystal formation [155]. 
The structure was subsequently determined by NMR spectroscopy. In the process of 
obtaining the NMR solution structure the adaptive nature of the RNA aptamer- ligand 
interaction was observed. Comparison of the 2D NOESY spectra of free MG aptamer to the 
MG aptamer : MG complex showed an increase in the number of narrow well defined 
NOESY peaks, as shown in Figure 3.1. The well defined NOESY peaks are characteristic 
for a more stable structure. The formation of a stable structure as a result of ligand binding is 
consistent with adaptive binding. The stem regions of MG aptamer can be identified in the 
2D NOESY spectra (Figure 3.2A) suggesting that the aptamer has some stable structure but 
lacks a defined binding pocket [156]. 
 
Figure 3.1 Sections of 2D NOESY spectra of MG aptamer and MG aptamer : MG (A) MG 
aptamer (first stem labeled red, second stem labeled blue) and (B) MG aptamer in 
the presence of the MG (the peaks pointed out are indicative of ligand binding). 
NMR obtained by Flinders and coworkers [156].   
MG aptamer : MG            MG aptamer  
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Figure 3.2A is a depiction of the lowest free energy secondary structure calculated 
by Kinefold [157, 158]. The stem regions are present as confirmed by the 2D NOESY 
spectra. Mutation studies varying different structural elements of the binding pocket were 
conducted, which are highlighted in Figure 3.2B. These studies showed that for the U turn 
(U25) the size of the base is important. The main purpose of the base triples (A27, C10, 
G23) and (A26, U11, A22) is to position U25 and the base quadruple (G24, A31, C7,G29) 
and G8-C28 base pair are important for stacking interactions with ligand [156].   
 
Figure 3.2  A) Kinefold predicted lowest free energy secondary structure of MG aptamer 
B) Secondary structure diagram showing the structural elements of the 
binding pocket groups: Base quadruple (yellow), base triples (red and green), 
G8-C28 base pair (blue), U 25 (orange) [157,158]. 
These conclusions were based on binding studies that measured the changes in the 
fluorescence intensity caused by binding of TMR to the MG aptamer. Similar binding 
studies were done to measure the affinity of pyronin Y (PY) to the MG aptamer. Binding 
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affinities of MG and crystal violet (CV) were determined by competitive inhibition of TMR 
binding detected by the change in fluorescence intensity. The structures of TMR, MG, PY 
and CV are shown in Figure 3.3 along with their KD values [155, 156].  
 
Figure 3.3  Structures of CV, MG, TMR and PY along with KD determined by 
fluorescence method described in text. The rings of MG are labeled A, B, C 
consistent with other chapters [155]. 
Based on these binding affinities it appeared that the MG aptamer had a greater 
affinity for TMR and PY than MG while CV has close to no affinity [155]. This is 
suspicious since PY lacks the third phenyl ring involved in crucial base stacking 
interactions. TMR and PY have planar structures that potentially allows for intercalation in 
non specific binding sites of the aptamers. Since MG binding affinity was based on the 
ability of MG to compete with TMR the resulting binding affinities would be affected by 
MG’s difficulty intercalating due to its non planar structure. CV which has three non planar 
54 
 
rings thereby appears to have no affinity. MG’s rings A and B are more planar than CV 
rings are capable of displacing some TMR, and appears to have low affinity.  
 
Figure 3.4   2D and 1D NMR spectra comparing MG and PY binding to MG aptamer; A and B, 
2D NOESY spectra of MG aptamer in the presence of MG and PY respectively; C 
and D 1D NOESY spectra of MG aptamer in the presence of MG and PY 
respectively. NMR spectra obtained by Dieckmann and coworkers. 
 
 Our skepticism of PY’s high binding affinity was raised when NMR structural data 
showed no bound complex formation when MG aptamer was in the presence of PY. 
Comparison of the 1D and 2D NMR spectra of MG aptamer: MG and MG aptamer: PY 
complexes (Figure 3.4) suggest that PY binds at multiple sites by intercalating into helical 
stems of MG aptamer rather than in the binding pocket. Therefore alternate methods of 
determining binding affinity were required. Equilibrium dialysis and isothermal calorimetry 




3.2 Equilibrium dialysis  
The equilibrium dissociation constant, KD (in M), is defined in the equation 3.1 
below 
 
(Equation 3.1)  
 
 
koff is the dissociation rate constant and kon is the association rate constant.  This means that 
when the concentration of ligand equals the KD, half the receptors will be occupied at 
equilibrium. If the receptor has a high affinity for the ligand, the KD will be low since it will 
take a low concentration of ligand to bind half the receptors. If the receptor has a low 
affinity for the ligand, the KD will be high since it will take a high concentration of ligand to 
bind the half receptors.  
Dialysis is the movement of molecules through a semi-permeable membrane that 
separates molecules based on size. Equilibrium dialysis involves two chambers, the ligand 
and the receptor chamber. They are separated by a semi-permeable membrane. The 
molecular weight allowed to pass through the membrane depends on the type of membrane. 
The ligand chamber contains the ligand, which can pass through the semi-permeable 
membrane. The receptor chamber contains the receptor that cannot pass through the semi 
permeable membrane. Binding of ligand to the receptor shifts the equilibrium of free ligand, 
causing more ligand to move into the receptor chamber. Figure 3.5 provides a summary of 











Figure 3.5  Simple illustration of equilibrium dialysis. Receptors are shown in red and 
ligands in green. t represents time [159]. 
3.3 Isothermal titration calorimetry 
Isothermal calorimetry (ITC) is based on the measurement of the enthalpy of a 
reaction. The ITC instrument does this by continuously monitoring the temperature and the 
power required to maintain the temperature of the reference cell and the sample cell. The 
ITC uses a reference cell to determine power required to maintain a desired temperature. 
The sample cell generally contains the receptor and the ligand is titrated into the cell by a 
syringe. A schematic of an ITC apparatus is shown in Figure 3.6 [160, 161].  
 
Figure 3.6  Schematic representation of ITC apparatus. Receptors are shown in red and 
ligands in green [160, 161]. 
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The difference in power required to maintain the temperature in the sample cell as 
the ligand is introduced is used to generate an energy versus ligand : receptor molar ratio 
plot. Computer software (ORIGIN) is then used to fit the data to an appropriate model and 
derive the binding constant (K), number of sites (n), molar enthalpy (ΔH), entropy (ΔS) and 
Gibbs free energy (ΔG). The relationship between these variables is given by equation 3.2 
[160, 161]. 
ΔG = -RT lnK = ΔH – TΔS    (Equation 3.2) 
ITC has been successfully used to determine the binding affinity between RNA molecules 
and potential drug molecules. ITC studies at different pH and temperature values were used 
to determine that binding of L-Tyrosinamide to its aptamer is an enthalpy driven process. 
Combined with the large negative entropy change upon binding and changes in the circular 
dichroism spectra this suggested an induced fit mechanism of binding [162]. 
3.4 Results and Discussion 
3.4.1 Preliminary equilibrium dialysis  
Equilibrium dialysis experiments were conducted to determine equilibrium 
dissociation constant for PY : MG aptamer complex. Initial results show that the binding 
curve levels off at a ratio of 5 bound dye/total dye (Figure 3.7A). This suggests that PY does 
not have a high affinity for the aptamer binding pocket and binds by intercalation into the 
helical stem regions. Since the binding pocket fits only one dye molecule, the binding curve 
expected for specific binding should show saturation at 1 bound dye/total RNA as is 
observed in the case of MG : MG aptamer dialysis (Figure 3.7B). This is consistent with the 
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idea that the third phenyl ring plays an important role for binding by providing additional 






Figure 3.7.  A) Binding curve from MG aptamer : PY equilibrium dialysis B) Binding 
curve from MG aptamer : MG equilibrium dialysis. 
3.4.2 Preliminary isothermal titration calorimetry  
 ITC experiments were conducted to determine the thermodynamic binding 
parameters for MG and TMR. Initial results are shown in Figure 3.8. The calculated values 
for KD, ΔH, ΔS, ΔG and n are summarized in Table 3.1. From the initial data it appears that 
between molar ratios of 0.0 to 3.0, MG and TMR have similar affinity for the MG aptamer. 
More data is needed before conclusions about the role of enthalpy and entropy in MG and 
TMR binding can be made. The variation in ΔH and ΔS does suggest that the interactions 
involved are different.  
The two dyes have similar free energies of binding (Table 3.1) which is expected 
since they have similar structure. The differences can be attributed to differences in 
planarity. TMR binding seems to be driven by a favorable enthalpy decrease. MG binding 
however, seems to be driven moderately by both enthalpy decrease and entropy increase.  
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Table 3.1:  Summary of ITC derived thermodynamic parameters for binding of MG and 
TMR to MG aptamer at 25oC 
Parameter MG Deviation* TMR Deviation* 
KD (M) 5.445E-07 1.342E-05 1.343E-06 1.356E-05 
N 1.54 0.00646 0.7665 0.0206 
ΔH (kcal/mol) -8.084 0.053 -19.920 0.734 
ΔS (cal/mol/deg) 1.722 1.198 -39.15 2.05 
ΔG (kcal/mol) -8.560 0.244 -8.207 0.554 
* KD, N, and ΔH deviation reported reflects the deviation of the experimental data from the fitted curves the duplicate ITC experiments 
that were conducted. ΔS and ΔG were calculated using equation 3.2 deviation reported reflects deviation between the duplicate ITC 
experiments. 
The larger negative enthalpy value seen for TMR binding (-19.920 kcal/mol) 
compared to MG binding (-8.084 kcal/mol) maybe due to increased favorable stacking 
interactions. This is consistent with stacking interactions seen in the crystal structure of the 
TMR : MG aptamer complex compared to the  MG : MG aptamer complex. The entropy 
increase upon binding (1.722 cal/mol/deg) seen for MG is likely a combination of 
unfavorable entropy due to loss of conformational freedom of MG combined with increased 
entropy from the asymmetrical distribution of charge across MG rings induced by binding. 
Binding to the aptamer has been shown to induce a more coplanar conformation of MG dye 
[163]. These results also agree with ab initio calculations that have shown a change in 
charge distribution induced by aptamer binding [164]. The unfavorable entropy seen for 
TMR binding (-39.15 cal/mol/deg) is also likely due to loss of conformation freedom from 
adaptive binding combined with a relatively low favorable entropy from the change in 
charge distribution. These conclusions require confirmation with ab initio calculations and 














Figure 3.8  A) Raw ITC data of MG into buffer control (black) and two separate MG into 
MG aptamer runs (red and blue). Plot of kcal/mole versus molar ratio for MG 
into MG aptamer red (B); blue (C), data points are shown as black dots, the 
line is the curve that has been fit to the data. D) Raw ITC data of TMR into 
buffer control (black) and two separate TMR into MG aptamer runs (red and 
blue) Plot of kcal/mole versus molar ratio for TMR into MG aptamer red (E); 
blue (F), data points are shown as black dots, the line is the curve that has 






The ITC binding studies need to be repeated at various pH, ionic strengths and 
temperatures to gain an accurate understanding of the thermodynamics of complex 
formation. Similar studies have used ITC to study the interaction between ethidium and 
cytotoxic plant alkaloids with RNA. The difference between entropy and enthalpy values 
has been used to suggest partial intercalation of alkaloids compared to ethidium, which 
intercalates into RNA [165].   
3.5 Materials and methods 
3.5.1 RNA preparation 
The MG aptamer used for ITC and equilibrium dialysis were prepared enzymatically 
from a synthetic DNA template by using T7 RNA polymerase and unlabeled NTPs, as 
described previously. [154, 166] To increase yield of the transcribed RNA, the DNA 
template was synthesized to include only purines in the firs t six transcribed nucleotides. 
After transcription, the pyrophosphate was removed by centrifugation and the RNA was 
collected by precipitation with ethanol. The RNA was then separated from NTPs using a 
Hiprep 26/10 Desalting column. The resulting RNA peak was then run on a Superdex 75 
10/300 GL column separating the MG aptamer from abortion products of the T7 RNA 
polymerase transcription. Further purification of the RNA involved a HiPrep 16/10 DEAE 
FF anion-exchange column, followed again by desalting on a Hiprep 26/10 Desalting 
column and lyophilization to dryness. The RNA was then resuspended in deionized water 
and filtered through Ultrafree-MC 10KDa centrifugal filter units (Millipore Corporation, 
Massachusetts, U.S.A). All columns used for RNA preparation were purchased from GE 





3.5.2 Ligand preparation 
Malachite green was purchased from Sigma Aldrich (Sigma-Aldrich Corporation, 
Milwaukee, U.S.A). Tetramethylrosamine was purchased from Invitrogen (Invitrogen 
Corporation, California, U.S.A). Pyronin Y was purchased from Acros Organics (Thermo 
Fisher Scientific Incorporated, Geel, Belgium). MG, TMR and PY were weighed, dissolved 
in water and stored as a 500μM stock solution.  
3.5.3 Equilibrium dialysis studies 
Solutions were prepared for dye and RNA chambers, in 500μ l eppendroff tubes. 
Both dye and RNA tubes received 12μ l of RNA buffer solution (final concentration of 
10mM acetate buffer and 100 mM KCl), followed by a volume of dye in dye chamber tube 
and RNA in RNA chamber tube, using increasing ratio of dye:RNA from 1:1 to 50:1. The 
tubes were then topped off to 60μ l. For increased delivery efficiency water was added first, 
then buffer and finally dye or RNA. The RNA concentrations used were 100μM and 300μM. 
Dye concentrations were 990μM malachite green, 990μM pyronin Y. Dye solutions were 
made by dissolving appropriate amount of solid dye (based on molecular weight) in H20. 
RNA and dye tubes were then pipetted into respective chambers and allowed to 
equilibrate for 32 hours while being gently agitated on an ocelot shaker (speed setting “A”).  
After equilibration, 50μ l was taken from each chamber and dissolved in 450μ l of acetic acid.  
Absorbance was measured at absorption maxima based on extinction coefficient ca lculated 
in glacial acetic acid. Concentration of dye was determined using a standard curve 
calculated by measuring the absorbance of varying concentration dye in glacial acetic acid. 
All absorbance values were determined using a Cary 4000 UV/Visible Spec. 
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3.5.4 Isothermal calorimetry studies 
Experiments were performed at 25oC on a MicroCal ITC 200 microcalorimeter 
(MicroCal, Inc., Northampton, Massachusetts). The 8μM RNA solution was prepared using 
Ultrafree-MC 10KDa centrifugal filter units (Millipore Corporation, Massachusetts, U.S.A) 
and washed four times with 20mM NaCl 10mM phosphate buffer, pH 6.0. The 100μM dye 
solutions were prepared by dissolving solid dye in 20mM NaCl 10mM phosphate buffer, pH 
6.0. The ITC cell was filled with RNA solution and was titrated with dye solution from the 
syringe. In order to account for heat of dilution of dye solution, a blank run with buffer in 
cell and dye in syringe was run and subtracted from the experimental run. All data sets were 
analyzed using Origin software provided by MicroCal and fitted to a one set of sites binding 
model that assumes a single set of equivalent binding sites.  
3.6 Future Work 
3.6.1 Isothermal calorimetry thermodynamic investigation 
ITC provides K, n, ΔH, ΔS and ΔG values. By varying pH, temperature and salt 
calculations the thermodynamic nature of the MG aptamer : dye complex formation can be 
further investigated. Comparing TMR binding to MG binding should provide insight into the 
differences between MG and TMR interactions with the RNA binding pocket.  
3.6.2 Mass spectroscopy binding studies 
Mass spectroscopy will be used to attempt to confirm the presence and extent of 
TMR non specific binding. This will require the use of tandem mass spectrometry to detect 
fragmentation patterns of RNA in the presence of TMR. Comparisons will be made to the 
fragmentation patterns obtained with MG bound and in the absence of any dye.  
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3.6.3 Axela Dot Lab system studies 
The Axela Dot Lab system (Axela Inc., Toronto, Canada) measures binding based on 
change in refraction caused by a change of height at the surface of a sensor chip. An MG 
derivative will be immobilized on the surface followed by introduction of MG aptamer. 
These studies will evaluate the ability of the Dot Lab system to detect small molecule to 
aptamer binding as well as providing another source of binding information to better 
understand the MG aptamer binding to dyes. Binding could conveniently be studied under 
different buffer conditions and results compared to ITC data. More importantly, the system 
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Figure 2B.  Mass spectra of MGNCS after 30 min at pH 1. MGNCS at 386.1479 m/z; 




Figure 2C.  Mass spectra of the MGNH2 synthesis product. The formation of MGNH2 








Figure 2D.  Mass spectra of the MGOH synthesis product. The formation of MGOH 













Figure 2E.  Mass spectra of the MGCOOCH3 synthesis product. The formation of 
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Figure 2G. Scheme for synthesis of MGCOOCH3. R represents COOCH3 group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
